article thumbnail

Arcturus Gets $11M For 3D Video Editing Tools

socalTECH

Los Angeles-based Arcturus, a developer of 3D video editing tools, said Wednesday afternoon that it has raised $11M in a Series A funding round. The startup is led by CEO Kamal Mistry. The funding was led by Cloudtree Ventures, and also included Autodesk and Epic Games.

Arcturus 100
article thumbnail

RNA Specialist Arcturus Therapeutics Gets $3M R&D Grant for CF Drug

Xconomy

San Diego-based Arcturus Therapeutics said today Cystic Fibrosis Foundation Therapeutics has agreed to provide $3 million to fund research and development of a new messenger RNA drug that could be broadly used to treat cystic fibrosis patients. Arcturus says its technology can be used to make.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Xconomy Q&A: An Update with Arcturus Therapeutics CEO Joseph Payne

Xconomy

Things have been moving quickly in recent weeks for the San Diego RNA drug developer Arcturus Therapeutics. After initiating a reverse merger last month, Arcturus signed a research collaboration and worldwide licensing agreement with Janssen Pharmaceuticals, part of the Johnson & Johnson (NYSE: JNJ ) family of companies.

article thumbnail

TrueCar Launches New Pricing Tool

socalTECH

Santa Monica-based TrueCar.com , the online automotive pricing startup headed up by Scott Painter, said Thursday that it has launched a new tool to help new car buyers. The firm is venture backed by Anthem Ventures, Arcturus Capital, Capital One, Capricorn Management, and GRP Partners. READ MORE>>.

Truecar 154
article thumbnail

Arcturus Terminates CEO, Names Mark Herber as Interim President

Xconomy

Arcturus Therapeutics (NASDAQ: ARCT ) said today it has fired co-founder and CEO Joseph E. The unexpected announcement nevertheless sent the price of Arcturus shares spiraling in after-hours trading, falling by $1.38, nearly 19 percent, to. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

article thumbnail

Settlement Ends Fight at Arcturus Therapeutics; New Board Named

Xconomy

The San Diego RNA drug developer Arcturus Therapeutics (NASDAQ: ARCT ) named four new board members Tuesday, after the four directors who fired founding CEO Joseph Payne resigned as part of a settlement agreement that was approved Monday by an Israeli court. No financial terms were disclosed.

article thumbnail

Sorrento Therapeutics Gets $2.3M

socalTECH

San Diego-based Sorrento Therapeutics , a new biotechnology startup, has raised $2.3M Dr. Schuh was previously CEO and Director of AviaraDx, and also served at Arcturus Bioscience and Sequenom. Schuh was previously CEO and Director of AviaraDx, and also served at Arcturus Bioscience and Sequenom.

Arcturus 100